Pfizer faces thousands of lawsuits linking Lipitor to type 2 diabetes

lipitor 435x435 Pfizer faces thousands of lawsuits linking Lipitor to type 2 diabetesFrom the time the cholesterol-lowering statin Lipitor (atorvastatin) hit the market in 1996, it has been the No. 1 best-selling prescription drug in the country, bringing in more than $130 billion in worldwide sales. More than 29 million people in the United States currently take the drug to control their cholesterol. However, this wonder drug comes with a price – an increased risk of type 2 diabetes. Now, thousands of former users have filed lawsuits against drug maker Pfizer alleging the company did not adequately warn users of this risk.

In 2012, the Food and Drug Administration (FDA) issued a safety warning alerting the public that studies showed the drug could increase blood sugar levels, putting users at risk for type 2 diabetes. Postmenopausal women who were not considered overweight were at the highest risk of developing the disease while using Lipitor.

Risk factors for type 2 diabetes include obesity, unhealthy diet and sedentary lifestyle. The condition is chronic, requiring patients to follow a strict diet and often take medications to keep their blood sugar levels in check. Uncontrolled diabetes can lead to heart disease, kidney disease, dementia, amputations from neuropathy, and blindness.

Following the FDA warning in 2012, lawsuits against Pfizer began to mount to the point that the federal panel has decided to consolidate the lawsuits in a Charleston, S.C., court.

Attorneys with Beasley Allen Law Firm are currently investigating cases of diabetes in patients who used Lipitor.

Source: Utah People’s Post